Hypertension News

1. This cheap drug could help people with type 1 diabetes use less insulin

   A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers initially hoped it would reduce insulin resistance, they instead found it allows patients to use about 12% less insulin while maintaining stable blood sugar levels.

2. Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason

   A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly.

3. Scientists reveal new blood pressure treatment that works when others fail

   A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t respond to standard treatments. In a large global trial, patients saw their blood pressure drop by nearly 10 mmHg, a meaningful reduction that can significantly lower the risk of heart attack, stroke, and kidney disease. By targeting a hormone that causes the body to retain salt and water, this treatment could offer a much-needed solution for millions struggling with uncontrolled hypertension.

4. A bold new plan could finally cure type 1 diabetes

   Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system from destroying transplanted cells — without using immunosuppressive drugs. Backed by $1 million in funding, the team hopes to create a ready-to-use treatment that could work even for people who have had diabetes for years. The approach could transform how the disease is treated.

5. American Heart Association warns 60% of US women will have cardiovascular disease by 2050

   Heart disease is on track to tighten its grip on American women. New projections from the American Heart Association warn that over the next 25 years, cardiovascular disease will rise sharply, driven largely by a surge in high blood pressure, diabetes, and obesity. By 2050, nearly 60% of women in the U.S. could have high blood pressure, and close to one in three women ages 22 to 44 may already be living with some form of heart disease.

6. This vegan diet cut insulin use by nearly 30% in type 1 diabetes

   A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need, and how much they spend on it. In a new analysis published in BMC Nutrition, participants following the plant-based plan lowered their daily insulin use by 28%, while those on a portion-controlled diet saw no meaningful change.

7. Blockbuster weight loss drugs like Ozempic deliver big results but face big questions

   Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common.

8. A quiet change in everyday foods could save thousands of lives

   Lowering salt in everyday foods could quietly save lives. Researchers found that modest sodium reductions in bread, packaged foods, and takeout meals could significantly reduce heart disease and stroke rates in France and the U.K. The key advantage is that people would not need to alter their eating habits at all. Small changes to the food supply could deliver large, long-term health benefits.